Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-21-002924
Date:2021-06-09
Issuer: OLEMA PHARMACEUTICALS, INC. (OLMA)
Original Submission Date:

Reporting Person:

LARSON YI
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR SAN FRANCISCO, CA 94107

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 27.66 2021-06-09 deemed execution date A 21,520 (a) 2031-06-08 common stock 21,520 $27.66 21,520 direct
Footnotes
IDfootnote
f1 the shares subject to the option vest in a series of 12 successive equal monthly installments measured from june 9, 2021, subject to the reporting person's continuous service through each applicable vesting date. such shares vest in full on the date of the issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the reporting person's continuous service through such vesting date.

Elevate your investments